Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma

Pulmonary pleomorphic carcinoma (PPC) is a rare disease with a poor prognosis. Most patients with PPC are refractory to chemotherapy, whereas good responses to platinum‐based chemotherapy in combination with the anti‐angiogenesis agent bevacizumab have been reported. An 82‐year‐old man was diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishioka, Naoya, Kaneko, Yoshiko, Yamada, Tadaaki, Okura, Naoko, Hirai, Soichi, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161404/
https://www.ncbi.nlm.nih.gov/pubmed/30275953
http://dx.doi.org/10.1002/rcr2.372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161404/
https://www.ncbi.nlm.nih.gov/pubmed/30275953
http://dx.doi.org/10.1002/rcr2.372

Ejemplares similares